1318 related articles for article (PubMed ID: 25319735)
1. Small Intestinal Transit Time Is Delayed in Small Intestinal Bacterial Overgrowth.
Roland BC; Ciarleglio MM; Clarke JO; Semler JR; Tomakin E; Mullin GE; Pasricha PJ
J Clin Gastroenterol; 2015 Aug; 49(7):571-6. PubMed ID: 25319735
[TBL] [Abstract][Full Text] [Related]
2. A Prospective Evaluation of Ileocecal Valve Dysfunction and Intestinal Motility Derangements in Small Intestinal Bacterial Overgrowth.
Chander Roland B; Mullin GE; Passi M; Zheng X; Salem A; Yolken R; Pasricha PJ
Dig Dis Sci; 2017 Dec; 62(12):3525-3535. PubMed ID: 28871499
[TBL] [Abstract][Full Text] [Related]
3. Low ileocecal valve pressure is significantly associated with small intestinal bacterial overgrowth (SIBO).
Roland BC; Ciarleglio MM; Clarke JO; Semler JR; Tomakin E; Mullin GE; Pasricha PJ
Dig Dis Sci; 2014 Jun; 59(6):1269-77. PubMed ID: 24795035
[TBL] [Abstract][Full Text] [Related]
4. Elevated methane levels in small intestinal bacterial overgrowth suggests delayed small bowel and colonic transit.
Suri J; Kataria R; Malik Z; Parkman HP; Schey R
Medicine (Baltimore); 2018 May; 97(21):e10554. PubMed ID: 29794732
[TBL] [Abstract][Full Text] [Related]
5. Lubiprostone Accelerates Intestinal Transit and Alleviates Small Intestinal Bacterial Overgrowth in Patients With Chronic Constipation.
Sarosiek I; Bashashati M; Alvarez A; Hall M; Shankar N; Gomez Y; McCallum RW; Sarosiek J
Am J Med Sci; 2016 Sep; 352(3):231-8. PubMed ID: 27650225
[TBL] [Abstract][Full Text] [Related]
6. Decompensated cirrhotics have slower intestinal transit times as compared with compensated cirrhotics and healthy controls.
Chander Roland B; Garcia-Tsao G; Ciarleglio MM; Deng Y; Sheth A
J Clin Gastroenterol; 2013; 47(10):888-93. PubMed ID: 23632359
[TBL] [Abstract][Full Text] [Related]
7. [Clinical features of irritable bowel syndrome with small intestinal bacterial overgrowth and a preliminary study of effectiveness of Rifaximin].
Liu ZJ; Wei H; Duan LP; Zhu SW; Zhang L; Wang K
Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(24):1896-902. PubMed ID: 27373356
[TBL] [Abstract][Full Text] [Related]
8. Validation of SmartPill
Diaz Tartera HO; Webb DL; Al-Saffar AK; Halim MA; Lindberg G; Sangfelt P; Hellström PM
Neurogastroenterol Motil; 2017 Oct; 29(10):1-9. PubMed ID: 28524600
[TBL] [Abstract][Full Text] [Related]
9. Obesity increases the risk of small intestinal bacterial overgrowth (SIBO).
Roland BC; Lee D; Miller LS; Vegesna A; Yolken R; Severance E; Prandovszky E; Zheng XE; Mullin GE
Neurogastroenterol Motil; 2018 Mar; 30(3):. PubMed ID: 28940740
[TBL] [Abstract][Full Text] [Related]
10. Impact of Oral-Cecal Transit Time on the Interpretation of Lactulose Breath Tests After RYGB: a Personalized Approach to the Diagnosis of SIBO.
Jirapinyo P; Makuvire TT; Dong WY; Chan WW; Thompson CC
Obes Surg; 2019 Mar; 29(3):771-775. PubMed ID: 30627990
[TBL] [Abstract][Full Text] [Related]
11. Clinical value of radionuclide small intestine transit time measurement combined with lactulose hydrogen breath test for the diagnosis of bacterial overgrowth in irritable bowel syndrome.
Ning Y; Lou C; Huang Z; Chen D; Huang H; Chen L; Zhang B; Dai N; Zhao J; Zhen X
Hell J Nucl Med; 2016; 19(2):124-9. PubMed ID: 27331205
[TBL] [Abstract][Full Text] [Related]
12. Comparison of lactulose and glucose breath test for diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome.
Rana SV; Sharma S; Kaur J; Sinha SK; Singh K
Digestion; 2012; 85(3):243-7. PubMed ID: 22472730
[TBL] [Abstract][Full Text] [Related]
13. Orocecal transit time and small intestinal bacterial overgrowth in type 2 diabetes patients from North India.
Rana S; Bhansali A; Bhadada S; Sharma S; Kaur J; Singh K
Diabetes Technol Ther; 2011 Nov; 13(11):1115-20. PubMed ID: 21770765
[TBL] [Abstract][Full Text] [Related]
14. Motility abnormalities in irritable bowel syndrome.
DuPont AW; Jiang ZD; Harold SA; Snyder N; Galler GW; Garcia-Torres F; DuPont HL
Digestion; 2014; 89(2):119-23. PubMed ID: 24503633
[TBL] [Abstract][Full Text] [Related]
15. Small intestinal bacterial overgrowth in patients suffering from scleroderma: clinical effectiveness of its eradication.
Parodi A; Sessarego M; Greco A; Bazzica M; Filaci G; Setti M; Savarino E; Indiveri F; Savarino V; Ghio M
Am J Gastroenterol; 2008 May; 103(5):1257-62. PubMed ID: 18422815
[TBL] [Abstract][Full Text] [Related]
16. Diagnosing Small Intestinal Bacterial Overgrowth: A Comparison of Lactulose Breath Tests to Small Bowel Aspirates.
Cangemi DJ; Lacy BE; Wise J
Dig Dis Sci; 2021 Jun; 66(6):2042-2050. PubMed ID: 32681227
[TBL] [Abstract][Full Text] [Related]
17. Evidence of prolonged orocecal transit time and small intestinal bacterial overgrowth in acromegalic patients.
Resmini E; Parodi A; Savarino V; Greco A; Rebora A; Minuto F; Ferone D
J Clin Endocrinol Metab; 2007 Jun; 92(6):2119-24. PubMed ID: 17405840
[TBL] [Abstract][Full Text] [Related]
18. Generalized transit delay on wireless motility capsule testing in patients with clinical suspicion of gastroparesis, small intestinal dysmotility, or slow transit constipation.
Kuo B; Maneerattanaporn M; Lee AA; Baker JR; Wiener SM; Chey WD; Wilding GE; Hasler WL
Dig Dis Sci; 2011 Oct; 56(10):2928-38. PubMed ID: 21625964
[TBL] [Abstract][Full Text] [Related]
19. Small intestinal bacterial overgrowth in patients with lower gastrointestinal symptoms and a history of previous abdominal surgery.
Petrone P; Sarkisyan G; Fernández M; Coloma E; Akopian G; Ortega A; Kaufman HS
Arch Surg; 2011 Apr; 146(4):444-7. PubMed ID: 21502453
[TBL] [Abstract][Full Text] [Related]
20. Levothyroxine therapy and impaired clearance are the strongest contributors to small intestinal bacterial overgrowth: Results of a retrospective cohort study.
Brechmann T; Sperlbaum A; Schmiegel W
World J Gastroenterol; 2017 Feb; 23(5):842-852. PubMed ID: 28223728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
